| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/17/2003 | EP0939624B1 Effervescent bisphosphonate formulation |
| 12/17/2003 | EP0928196B1 Beta-glucan products and extraction processes from cereals |
| 12/17/2003 | EP0852490B1 Emulsion formulations for the delivery of nucleic acids to cells |
| 12/17/2003 | EP0831820B1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 12/17/2003 | CN1462310A Process for producing isomaltose and use thereof |
| 12/17/2003 | CN1462309A Codon-optimized papilloma virus sequences |
| 12/17/2003 | CN1462193A Oral preparations |
| 12/17/2003 | CN1462187A Analgesic/antiinflammatary patches for topical use |
| 12/17/2003 | CN1462185A Improved transdermal therapeutic system for treatment of Parkinson's disese |
| 12/17/2003 | CN1461639A Slow-releasing injection contg. hydrocastor oil/medicine (for treatment) solid dispersion microparticle |
| 12/17/2003 | CN1131314C Recombination eukaryotic carrier containing sensitinogen gene and application thereof |
| 12/17/2003 | CN1131271C Carrangeenan compositions and process for their production |
| 12/17/2003 | CN1131070C Method for removal virus A. and pharmacal composite for treating disease caused by virus a. |
| 12/17/2003 | CN1131034C Novel pharmaceutical composition |
| 12/17/2003 | CN1131033C Anaesthetic formulation |
| 12/17/2003 | CN1131032C Benzimidzole enteric coating preparation and preparing method thereof |
| 12/17/2003 | CN1131028C Once-a-day methoprolol oral dosage form |
| 12/17/2003 | CN1131027C Controlled release formulation for poorly soluble basic drugs |
| 12/17/2003 | CN1131026C Valaciclovir tablets containing colloidal silicon dioxide |
| 12/17/2003 | CN1131023C Sustained release excipient |
| 12/16/2003 | US6664429 Unsaturated fatty alcohol polyglycol ethers which, through the presence of branches in the hydrocarbon chain, are distinguished from linear homologs by significantly improved properties |
| 12/16/2003 | US6664331 Poly(ethylene glycol) derivatives with proximal reactive groups |
| 12/16/2003 | US6664294 Compounds which have excellent antimicrobial activity, even at very low concentrations, and which is retained in presence of salt-containing media, such as saline solutions |
| 12/16/2003 | US6664284 Stabilized carvedilol injection solution |
| 12/16/2003 | US6664246 > 1 x 10-7 mole per liter of a vitamin D compound in an acceptable lipid; anticancer agents |
| 12/16/2003 | US6664040 Complexing to polypeptides; antiproliferation agent |
| 12/16/2003 | US6663901 Itraconazole; sugar core, a coating film of a water soluble polymer, a seal coating |
| 12/16/2003 | US6663900 Processed in a fluidized bed coating machine where a protective coating of a sugar or polyhydric alcohol, starch |
| 12/16/2003 | US6663897 Oral itraconazole formulations and methods of making the same |
| 12/16/2003 | US6663889 Ambroxol-containing lozenge |
| 12/16/2003 | US6663887 Compounds and compositions for delivering active agents |
| 12/16/2003 | US6663881 Therapeutic inhibitor of vascular smooth muscle cells |
| 12/16/2003 | US6663878 Anti-inflammatory bioactive glass particulates |
| 12/16/2003 | US6663869 Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid |
| 12/16/2003 | US6663868 Heat shock protein-based vaccines and immunotherapies |
| 12/16/2003 | US6662805 Method for composite cell-based implants |
| 12/16/2003 | CA2259297C Parenteral paclitaxel in a stable non-toxic formulation |
| 12/16/2003 | CA2218737C Cytomodulating conjugates of members of specific binding pairs |
| 12/16/2003 | CA2124578C A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 12/16/2003 | CA2110331C Desiccant, dehydration therewith, and dehydrated product obtainable thereby |
| 12/16/2003 | CA2096604C Protein c derivatives |
| 12/14/2003 | CA2432231A1 Liquid antacid compositions |
| 12/11/2003 | WO2003102583A1 Targeted therapeutic proteins |
| 12/11/2003 | WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 12/11/2003 | WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 12/11/2003 | WO2003102150A2 Multi-functional polyamines for delivery of biologically-active polynucleotides |
| 12/11/2003 | WO2003102116A2 Oil-soluble pigment compositions |
| 12/11/2003 | WO2003102014A2 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
| 12/11/2003 | WO2003102001A1 Polyol-modified silanes as precursors for silica |
| 12/11/2003 | WO2003101539A1 Self-administered contraceptive injection of oily solution |
| 12/11/2003 | WO2003101496A1 Methods and compositions for intravesical therapy of bladder cancer |
| 12/11/2003 | WO2003101495A1 Methods and compositions for radioimmunotherapy of brain and cns tumors |
| 12/11/2003 | WO2003101494A1 Materials and methods relating to polyions and substance delivery |
| 12/11/2003 | WO2003101493A1 Intravenous composition, process for producing the same and preparation thereof |
| 12/11/2003 | WO2003101486A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 12/11/2003 | WO2003101484A1 Compositions and methods for transepithelial molecular transport |
| 12/11/2003 | WO2003101480A1 Topical drug delivery using phosphatidylcholine |
| 12/11/2003 | WO2003101476A1 Active agent delivery systems and methods for protecting and administering active agents |
| 12/11/2003 | WO2003101473A1 Suicide tetramers comprising mhc class i and uses thereof |
| 12/11/2003 | WO2003101470A1 Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid |
| 12/11/2003 | WO2003101468A1 Method for the protection of endothelial and epithelial cells during chemotherapy |
| 12/11/2003 | WO2003101467A1 Pharmaceutical compositions comprising abacavir and lamivudine |
| 12/11/2003 | WO2003101465A1 Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same |
| 12/11/2003 | WO2003101461A1 Norethindrone sustained release formulations and methods associated therewith |
| 12/11/2003 | WO2003101460A1 External preparations for treating dermatitis |
| 12/11/2003 | WO2003101457A1 Peritoneal dialysis solution with taurolidine |
| 12/11/2003 | WO2003101454A1 A buffered, liquid nicotine composition for pulmonary administration |
| 12/11/2003 | WO2003101451A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 12/11/2003 | WO2003101446A1 A herbal molecule as potential anti-leukemic drug |
| 12/11/2003 | WO2003101445A1 Intravenous rifalazil formulation and methods of use thereof |
| 12/11/2003 | WO2003101438A1 Treatment for human papillomavirus |
| 12/11/2003 | WO2003101433A1 Plaster containing fentanyl |
| 12/11/2003 | WO2003101430A1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 12/11/2003 | WO2003101428A1 Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
| 12/11/2003 | WO2003101427A1 Immunoliposomes formed with aggregated antibody |
| 12/11/2003 | WO2003101425A2 Therapeutic agent-containing polymeric nanoarticles |
| 12/11/2003 | WO2003101424A1 Modified release pharmaceutical formulation |
| 12/11/2003 | WO2003101423A1 Immediate release pharmaceutical formulation |
| 12/11/2003 | WO2003101422A2 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents |
| 12/11/2003 | WO2003101421A1 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 12/11/2003 | WO2003101420A1 Film-shaped, dissolvable preparations for active substance release and method for the production thereof |
| 12/11/2003 | WO2003101404A2 Preparations for topical skin use and treatment |
| 12/11/2003 | WO2003101402A2 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 12/11/2003 | WO2003101395A2 Formulations for amylin agonist peptides |
| 12/11/2003 | WO2003101392A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 12/11/2003 | WO2003101384A2 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
| 12/11/2003 | WO2003101357A1 Transmucosal delivery of cannabinoids |
| 12/11/2003 | WO2003101217A1 Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 12/11/2003 | WO2003101196A1 Antimicrobial envelopes |
| 12/11/2003 | WO2003075904A3 Cyclodextrin complexed artemisinins |
| 12/11/2003 | WO2003074568A9 Individualized anti-cancer antibodies |
| 12/11/2003 | WO2003063772A3 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies |
| 12/11/2003 | WO2003060074A3 Novel metastasis suppressor gene on human chromosome 8 |
| 12/11/2003 | WO2003059333A3 Stimulation of the immune system with polydextrose |
| 12/11/2003 | WO2003055526A3 Erythropoietin conjugates |
| 12/11/2003 | WO2003051300A3 Metal complexes and formulations of rifamycin analogues and uses therof |
| 12/11/2003 | WO2003050190A3 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 12/11/2003 | WO2003048306A3 Polycistronic expression of antibodies |
| 12/11/2003 | WO2003040365A3 Pna-conjugate or pna-conjugate mixture for treating diseases related to the human papillomavirus |
| 12/11/2003 | WO2003035827A3 Plasticized hydrophilic glasses for improved stabilization of biological agents |